We are live on ! Find out more
BGM

Burkehill Global Management Portfolio holdings

AUM $2.77B
1-Year Est. Return 65.75%
This Fund
S&P 500
This Quarter Est. Return
+18.92%
1 Year Est. Return
+65.75%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.77B
AUM Growth
+$753M
Cap. Flow
+$549M
Cap. Flow %
19.8%
Top 10 Hldgs %
56.59%
Holding
245
New
66
Increased
5
Reduced
13
Closed
72

Top Buys

Rank Stock Value
1
SPCX
SpaceX
SPCX
+$637M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$180M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$179M
4
O icon
Realty Income
O
+$77.9M
5
AAPL icon
Apple
AAPL
+$77.2M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$133M
2
FANG icon
Diamondback Energy
FANG
+$132M
3
SNDK
Sandisk
SNDK
+$79.4M
4
NRG icon
NRG Energy
NRG
+$65.8M
5
GFS icon
GlobalFoundries
GFS
+$57.2M

Sector Composition

Rank Sector Weight
1 Industrials 34.25%
2 Communication Services 15.05%
3 Technology 13.39%
4 Real Estate 12.74%
5 Healthcare 11.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MH
151
McGraw Hill
MH
$2.44B
$947K 0.03%
100,000
– –
LRMR icon
152
Larimar Therapeutics
LRMR
$424M
$915K 0.03%
300,000
– –
WVE icon
153
Wave Life Sciences
WVE
$968M
$872K 0.03%
150,000
– –
IVA
154
Inventiva
IVA
$1.1B
$851K 0.03%
+225,000
New +$1.08M
NTLA icon
155
Intellia Therapeutics
NTLA
$1.79B
$846K 0.03%
+50,000
New +$700K
KARD
156
Kardigan Inc
KARD
$2.02B
$716K 0.03%
+30,000
New +$694K
EVMN
157
Evommune Inc
EVMN
$475M
$665K 0.02%
50,000
– –
KMTS
158
Kestra Medical Technologies
KMTS
$1.5B
$636K 0.02%
25,000
-25,000
-50% -$523K
MANE
159
Veradermics Inc
MANE
$4.34B
$615K 0.02%
5,000
– –
LXEO icon
160
Lexeo Therapeutics
LXEO
$391M
$582K 0.02%
125,000
– –
SPTX
161
Seaport Therapeutics
SPTX
$1.29B
$543K 0.02%
+25,000
New +$440K
ACET icon
162
Adicet Bio
ACET
$91.1M
$540K 0.02%
62,500
– –
AGMB
163
AgomAb Therapeutics NV
AGMB
$734M
$454K 0.02%
35,000
– –
KEEL
164
Keel Infrastructure Corp
KEEL
$2.3B
$435K 0.02%
+75,700
New +$325K
ODTX
165
Odyssey Therapeutics
ODTX
$1.3B
$374K 0.01%
+20,000
New +$351K
FRBT
166
Forbright Inc
FRBT
$960M
$366K 0.01%
+20,000
New +$362K
CNTB
167
Connect Biopharma Holdings
CNTB
$120M
$357K 0.01%
150,000
– –
PRQR icon
168
ProQR Therapeutics
PRQR
$289M
$328K 0.01%
+176,243
New +$290K
PBLS
169
Parabilis Medicines Inc
PBLS
$4.91B
$274K 0.01%
+10,000
New +$276K
ADT icon
170
ADT
ADT
$5.27B
– –
-1,500,000
Closed -$9.86M
AMKR icon
171
Amkor Technology
AMKR
$12.6B
– –
-800,000
Closed -$36M
ASPI icon
172
ASP Isotopes
ASPI
$647M
– –
-250,000
Closed -$1.1M
AVAH icon
173
Aveanna Healthcare
AVAH
$2.98B
– –
-275,000
Closed -$1.77M
CENX icon
174
Century Aluminum
CENX
$4.75B
– –
-150,000
Closed -$8.8M
CHWY icon
175
Chewy
CHWY
$9.53B
– –
-600,000
Closed -$16.2M
5 6
7
8 9

Similar funds

C
Consulta London, United Kingdom $2.77B AUM 3.62% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return
SIM
Stratos Investment Management Beachwood, Ohio $2.77B AUM 20.35% 1-Year Est. Return
JHP
James Hambro & Partners London, United Kingdom $2.76B AUM 19.67% 1-Year Est. Return
CAAS
Capital Asset Advisory Services Williamston, Michigan $2.76B AUM 18.08% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
CCM
Chickasaw Capital Management Memphis, Tennessee $2.78B AUM 20.87% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.78B AUM 23.76% 1-Year Est. Return

Burkehill Global Management's Q2 2026 Portfolio in Review

As of Q2 2026, Burkehill Global Management held 245 positions worth $2.77B, up 37% from $2.02B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Burkehill Global Management deployed $549M of net new capital in Q2 2026, opening 66 new positions and adding to 5 existing holdings. Its largest new stake was SpaceX: 3,750,000 shares worth $641M.

By sector, the portfolio is most concentrated in Industrials at 34% of assets, up from 19% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Galaxy Digital Inc, an estimated $33.4M trimmed.

  • Burkehill Global Management's largest Q2 2026 buy was SpaceX: 3,750,000 shares worth $641M.
  • Burkehill Global Management added most to SOLV Energy Inc in Q2 2026, an estimated $9.43M increase.
  • Burkehill Global Management's biggest Q2 2026 reduction was Galaxy Digital Inc, cutting an estimated $33.4M.
  • Burkehill Global Management fully exited Eli Lilly in Q2 2026, selling an estimated $133M.
  • Burkehill Global Management's ten largest holdings make up 57% of its $2.77B portfolio in Q2 2026.
  • Burkehill Global Management opened 66 new positions and closed 72 in Q2 2026.
  • Burkehill Global Management's portfolio value rose 37% quarter-over-quarter to $2.77B.

Based on Burkehill Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.